Investigational Site Number : 2030001

Ostrava - Vitkovice 703 84

0 studies enrolling now · 1 studies all time

What they study most

Non-small Cell Lung Cancer Metastatic

Studies at this site

• Tusamitamab Ravtansine (SAR408701) in Combination With Ramucirumab or Ramucirumab and Pembrolizumab in Pretreated Patients With NSQ NSCLC (CARMEN-LC04) — Stopped early